NanoLogix Introduces New ‘Petri Flat Pack’, to Exhibit at American Society for Microbiology Annual Meeting in New Orleans...
May 17 2011 - 5:00AM
Business Wire
NanoLogix (OTC MARKETS: NNLX), a biotechnology innovator in the
rapid detection and identification of live-cell bacteria and
microorganisms, announced today its latest innovation for the
microbial diagnostic industry, the Flat Pack. The company has
applied for a patent for this new packaging method to improve on
conventional Petri packaging practices. The Flat Pack method more
effectively protects the quality and integrity of NanoLogix
BioNanoPore (BNP) and BioNanoFilter (BNF) Rapid Test Kits during
both shipment and long-term storage, for all types of laboratory
settings and locations.
NanoLogix Flat Pack packaging method
vacuum seals the BioNanoPore (BNP) Rapid Test Kits to protect them
from damage and contamination, making it an ideal method for easy
stacking and long-term storage. (Photo: Business Wire)
The NanoLogix Flat Pack is a practical solution to the common
challenges of traditional packaging, which expose plates to
cracking and contamination by wrapping stacks of dishes in
thin-film plastic. By contrast, the NanoLogix Flat Pack method
vacuum seals a single layer of BNP/BNF Test Kits between two sheets
of thick plastic. The process of vacuum-packaging protects the kits
from damage and creates a sterile environment to prevent
contamination from the outside air. In addition, the flat surface
of the Flat Pack, allows for easy storage and direct visibility of
product quality.
“We are pleased with the innovation of our Flat Pack packaging,”
said Bret Barnhizer, NanoLogix CEO. “The sterile environment of the
vacuum seal demonstrates our commitment to high-quality rapid
diagnostics, no matter what type of use or laboratory location.
From the hospital and the manufacturing floor, to biodefense
operations and developing regions the Flat Pack ensures our
products arrive intact and are ready for use at a moment’s
notice.”
NanoLogix to Exhibit at American Society for Microbiology
General Meeting in New Orleans
The new Flat Pack will be on display along with the NanoLogix
BNP, BNF and Quick Test kits at the 111th American Society for
Microbiology General Meeting, in New Orleans, May 21-24th.
NanoLogix management and science personnel will be on hand at booth
#445 to demonstrate the company’s latest innovations. More
information on the conference can be found at
http://gm.asm.org.
New NanoLogix Website
NanoLogix also announced today a comprehensive upgrade to its
website www.nanologix.com. The new site features detailed
information on NanoLogix test results, third-party collaborations
and extensive data on the wide variety of pathogens and industry
applications suitable for the company’s rapid tests. To view the
new site please visit http://www.nanologix.com/.
NanoLogix Clinical Trial Scheduled for Presentation
Results for one of the clinical trial phases undertaken by the
University of Texas Health Science Center - Houston have been
accepted for poster display and presentation at a major Obstetrics
and Gynecology conference scheduled for autumn 2011. Additional
information to follow as the date draws near.
About NanoLogix, Inc.
NanoLogix is a biotechnology company focused primarily on rapid
diagnostics. Its products offer accelerated detection and
identification of microorganisms. In addition to medical and
homeland security applications, NanoLogix technology is applicable
in pharmaceutical, industrial, veterinary and environmental
testing. Patents granted to NanoLogix can be used in the areas of
applied microbiology, soil microbiology and bioremediation,
microbial physiology, molecular biology, pharmacology,
pharmaco-kinetics, and antibiotic sensitivity. For more information
visit www.nanologix.com.
This press release contains statements, which may constitute
"forward- looking statements" within the meaning of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended by
the Private Securities Litigation Reform Act of 1995. Those
statements include statements regarding the intent, belief or
current expectations of NanoLogix, Inc., and members of its
management as well as the assumptions on which such statements are
based. Prospective investors are cautioned that any such
forward-looking statements are not guarantees of future performance
and involve risks and uncertainties, and that actual results may
differ materially from those contemplated by such forward-looking
statements. The Company undertakes no obligation to update or
revise forward-looking statements to reflect changed assumptions,
the occurrence of unanticipated events or changes to future
operating results.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6726382&lang=en
NanoLogix (CE) (USOTC:NNLX)
Historical Stock Chart
From Jun 2024 to Jul 2024
NanoLogix (CE) (USOTC:NNLX)
Historical Stock Chart
From Jul 2023 to Jul 2024